Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

Delayed Data
As of Oct 26
 +0.15 / +0.77%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 43.00, with a high estimate of 60.00 and a low estimate of 20.00. The median estimate represents a +117.72% increase from the last price of 19.75.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 35.60%
Growthannually -55.09%


Growthquarterly 4.82%
Growthannually 3.94%
Key to the earnings and sales forecast charts.